Curi Wealth Management, LLC Albireo Pharma, Inc. Transaction History

Curi Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$18.54 - $37.29 $10,197 - $20,509	-550 Reduced 77.14%	163 $3,000
Q1 2022 May 06, 2022	BUY	$23.94 - $33.74 $2,130 - $3,002	89 Added 14.26%	713 $21,000
Q4 2021 Feb 09, 2022	BUY	$21.19 - $31.29 $13,222 - $19,524	624 New	624 $14,000
Q1 2021 Apr 29, 2021	SELL	$32.03 - $42.85 $10,409 - $13,926	-325 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$31.56 - $42.16 $10,257 - $13,701	325 New	325 $12,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.